Tue, June 25, 2024
Mon, June 24, 2024
Fri, June 21, 2024
Thu, June 20, 2024
Wed, June 19, 2024
Tue, June 18, 2024

Yasmeen Rahimi Maintained (ALT) at Buy and Held Target at $25 on, Jun 21st, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-25-on-jun-21st-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Yasmeen Rahimi of Piper Sandler, Maintained "Altimmune, Inc." (ALT) at Buy and Held Target at $25 on, Jun 21st, 2024.

Yasmeen has made no other calls on ALT in the last 4 months.



There are 4 other peers that have a rating on ALT. Out of the 4 peers that are also analyzing ALT, 1 agrees with Yasmeen's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Seamus Fernandez of "Guggenheim" Downgraded from Strong Buy to Hold on, Monday, April 29th, 2024


These are the ratings of the 3 analyists that currently disagree with Yasmeen


  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $12 on, Tuesday, May 14th, 2024
  • Jonathan Wolleben of "JMP Securities" Maintained at Buy with Decreased Target to $24 on, Friday, May 10th, 2024
  • Mayank Mamtani of "B. Riley Securities" Reiterated at Strong Buy and Held Target at $20 on, Thursday, March 28th, 2024

Publication Contributing Sources